Skip to main content
Open
Question
Forecasts
Track record
Unknowns
How it works
Sources
FAQ
Menu
← Evidence map
Review
Drugs
2023
Sovateltide: First Approval.
Susan J Keam
PubMed ↗
Publisher ↗
No numbers read from the abstract.
11 papers cite it
2023
2024
2025
2026
this paper
trial
cites it
The trial
NCT05691244
phase 3
514 enrolled
2025
Sovateltide: First Approval. | OpenQuestion